Jun 24, 2022· Comment from Consumer Healthcare Products Association (CHPA)· FDA-2022-N-0236-0023
Please find attached comments from the Consumer Healthcare Products Association. Feel free to contact me with any questions. Regards, Jay Sirois
FDANonrulemakingFDA-2022-N-0236
Prioritizing the Addition of Maximum Daily Exposure Information and Removing Dosage Form Information From the Inactive Ingredient Database; Establishment of a Public Docket; Request for Comments
RIN
—
Last modified
Jun 24, 2022
Comment window
closed 1498d ago
Consumer Healthcare Products Association filings
1
Activity
Consumer Healthcare Products Association filed 1 comment on this docket between Jun 24, 2022 and Jun 24, 2022. 0 other organizations filed here. The comment window closed 1498d ago.
What Consumer Healthcare Products Association filed (1)
Abstract
No abstract recorded.
View on regulations.gov →Co-filers (0)
See everyone who commented →- Consumer Healthcare Products AssociationTHIS ORG1 filing · confidence 97%